86 related articles for article (PubMed ID: 25542879)
1. Arterial spin-labeling perfusion MRI stratifies progression-free survival and correlates with epidermal growth factor receptor status in glioblastoma.
Qiao XJ; Ellingson BM; Kim HJ; Wang DJ; Salamon N; Linetsky M; Sepahdari AR; Jiang B; Tian JJ; Esswein SR; Cloughesy TF; Lai A; Nghiemphu L; Pope WB
AJNR Am J Neuroradiol; 2015 Apr; 36(4):672-7. PubMed ID: 25542879
[TBL] [Abstract][Full Text] [Related]
2. 3D Pseudocontinuous Arterial Spin-Labeling MR Imaging in the Preoperative Evaluation of Gliomas.
Zeng Q; Jiang B; Shi F; Ling C; Dong F; Zhang J
AJNR Am J Neuroradiol; 2017 Oct; 38(10):1876-1883. PubMed ID: 28729293
[TBL] [Abstract][Full Text] [Related]
3. In vivo evaluation of EGFRvIII mutation in primary glioblastoma patients via complex multiparametric MRI signature.
Akbari H; Bakas S; Pisapia JM; Nasrallah MP; Rozycki M; Martinez-Lage M; Morrissette JJD; Dahmane N; O'Rourke DM; Davatzikos C
Neuro Oncol; 2018 Jul; 20(8):1068-1079. PubMed ID: 29617843
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers for glioma immunotherapy: the next generation.
Sims JS; Ung TH; Neira JA; Canoll P; Bruce JN
J Neurooncol; 2015 Jul; 123(3):359-72. PubMed ID: 25724916
[TBL] [Abstract][Full Text] [Related]
5. Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma.
Lu-Emerson C; Duda DG; Emblem KE; Taylor JW; Gerstner ER; Loeffler JS; Batchelor TT; Jain RK
J Clin Oncol; 2015 Apr; 33(10):1197-213. PubMed ID: 25713439
[TBL] [Abstract][Full Text] [Related]
6. Hyperthermia Sensitizes Glioma Stem-like Cells to Radiation by Inhibiting AKT Signaling.
Man J; Shoemake JD; Ma T; Rizzo AE; Godley AR; Wu Q; Mohammadi AM; Bao S; Rich JN; Yu JS
Cancer Res; 2015 Apr; 75(8):1760-9. PubMed ID: 25712125
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of myosin-dependent contractility sensitizes glioma tumor-initiating cells to mechanical inputs and reduces tissue invasion.
Wong SY; Ulrich TA; Deleyrolle LP; MacKay JL; Lin JM; Martuscello RT; Jundi MA; Reynolds BA; Kumar S
Cancer Res; 2015 Mar; 75(6):1113-22. PubMed ID: 25634210
[TBL] [Abstract][Full Text] [Related]
8. Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab.
Leu K; Enzmann DR; Woodworth DC; Harris RJ; Tran AN; Lai A; Nghiemphu PL; Pope WB; Cloughesy TF; Ellingson BM
Cancer Imaging; 2014 Nov; 14(1):31. PubMed ID: 25608485
[TBL] [Abstract][Full Text] [Related]
9. Diffusion and perfusion MRI to differentiate treatment-related changes including pseudoprogression from recurrent tumors in high-grade gliomas with histopathologic evidence.
Prager AJ; Martinez N; Beal K; Omuro A; Zhang Z; Young RJ
AJNR Am J Neuroradiol; 2015 May; 36(5):877-85. PubMed ID: 25593202
[TBL] [Abstract][Full Text] [Related]
10. MRI perfusion measurements calculated using advanced deconvolution techniques predict survival in recurrent glioblastoma treated with bevacizumab.
Harris RJ; Cloughesy TF; Hardy AJ; Liau LM; Pope WB; Nghiemphu PL; Lai A; Ellingson BM
J Neurooncol; 2015 May; 122(3):497-505. PubMed ID: 25773062
[TBL] [Abstract][Full Text] [Related]
11. Relative cerebral blood volume is a potential predictive imaging biomarker of bevacizumab efficacy in recurrent glioblastoma.
Kickingereder P; Wiestler B; Burth S; Wick A; Nowosielski M; Heiland S; Schlemmer HP; Wick W; Bendszus M; Radbruch A
Neuro Oncol; 2015 Aug; 17(8):1139-47. PubMed ID: 25754089
[TBL] [Abstract][Full Text] [Related]
12. Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: a multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastoma.
Ellingson BM; Kim E; Woodworth DC; Marques H; Boxerman JL; Safriel Y; McKinstry RC; Bokstein F; Jain R; Chi TL; Sorensen AG; Gilbert MR; Barboriak DP
Int J Oncol; 2015 May; 46(5):1883-92. PubMed ID: 25672376
[TBL] [Abstract][Full Text] [Related]
13. Multi-TI Arterial Spin Labeling MRI with Variable TR and Bolus Duration for Cerebral Blood Flow and Arterial Transit Time Mapping.
Johnston ME; Lu K; Maldjian JA; Jung Y
IEEE Trans Med Imaging; 2015 Jun; 34(6):1392-402. PubMed ID: 25616010
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Multigland Disease in Primary Hyperparathyroidism: A Scoring System with 4D-CT Imaging and Biochemical Markers.
Sepahdari AR; Bahl M; Harari A; Kim HJ; Yeh MW; Hoang JK
AJNR Am J Neuroradiol; 2015 May; 36(5):987-92. PubMed ID: 25556203
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced MRI radiomics model predicts epidermal growth factor receptor amplification in glioblastoma, IDH-wildtype.
Sohn B; Park K; Ahn SS; Park YW; Choi SH; Kang SG; Kim SH; Chang JH; Lee SK
J Neurooncol; 2023 Sep; 164(2):341-351. PubMed ID: 37689596
[TBL] [Abstract][Full Text] [Related]
16. Prediction of short-term treatment outcome of nasopharyngeal carcinoma based on voxel incoherent motion imaging and arterial spin labeling quantitative parameters.
Liao L; Liu T; Wei B
Eur J Radiol Open; 2023; 10():100466. PubMed ID: 36590328
[TBL] [Abstract][Full Text] [Related]
17. Increased ASF1B Expression Correlates With Poor Prognosis in Patients With Gliomas.
Zhu H; Ouyang H; Pan X; Zhang Z; Tan J; Yu N; Li M; Zhao Y
Front Oncol; 2022; 12():912101. PubMed ID: 35875094
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic Imaging in Cerebral Diffuse Glioma-Part B: Molecular Correlates, Treatment Effect Monitoring, Prognosis, and Future Directions.
Stumpo V; Guida L; Bellomo J; Van Niftrik CHB; Sebök M; Berhouma M; Bink A; Weller M; Kulcsar Z; Regli L; Fierstra J
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267650
[TBL] [Abstract][Full Text] [Related]
19. 3D pCASL-perfusion in preoperative assessment of brain gliomas in large cohort of patients.
Batalov AI; Zakharova NE; Pronin IN; Belyaev AY; Pogosbekyan EL; Goryaynov SA; Bykanov AE; Tyurina AN; Shevchenko AM; Solozhentseva KD; Nikitin PV; Potapov AA
Sci Rep; 2022 Feb; 12(1):2121. PubMed ID: 35136119
[TBL] [Abstract][Full Text] [Related]
20. Perfusion measurement in brain gliomas using velocity-selective arterial spin labeling: comparison with pseudo-continuous arterial spin labeling and dynamic susceptibility contrast MRI.
Qu Y; Kong D; Wen H; Ou X; Rui Q; Wang X; Lin DD; Qin Q; Wen Z
Eur Radiol; 2022 May; 32(5):2976-2987. PubMed ID: 35066634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
